Earlier in January, Merck Chief Executive RichardClarkRichard Clark said he expected Vytorin to keep a secure position in the cholesterol drug market and cited several other ongoing studies in addition to this one.

FORBES: Magazine Article

Earlier in January, Merck Chief Executive Richard Clark said he expected Vytorin to keep a secure position in the cholesterol drug market and cited several other ongoing studies in addition to this one.

FORBES: Merck, Schering Study Falls Flat